IT8222209A0 - Agenti anti-obesita'. - Google Patents
Agenti anti-obesita'.Info
- Publication number
- IT8222209A0 IT8222209A0 IT8222209A IT2220982A IT8222209A0 IT 8222209 A0 IT8222209 A0 IT 8222209A0 IT 8222209 A IT8222209 A IT 8222209A IT 2220982 A IT2220982 A IT 2220982A IT 8222209 A0 IT8222209 A0 IT 8222209A0
- Authority
- IT
- Italy
- Prior art keywords
- obesity agents
- obesity
- agents
- Prior art date
Links
- 239000000883 anti-obesity agent Substances 0.000 title 1
- 229940125710 antiobesity agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8120961 | 1981-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8222209A0 true IT8222209A0 (it) | 1982-07-02 |
| IT1157288B IT1157288B (it) | 1987-02-11 |
Family
ID=10523079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT22209/82A IT1157288B (it) | 1981-07-07 | 1982-07-02 | Agenti anti-obesita' |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4451465A (it) |
| JP (1) | JPS5815915A (it) |
| AU (1) | AU558020B2 (it) |
| BE (1) | BE893789A (it) |
| IT (1) | IT1157288B (it) |
| ZA (1) | ZA824382B (it) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344481B1 (en) | 1999-03-01 | 2002-02-05 | Pfizer Inc. | Thyromimetic antiobesity agents |
| US7504435B2 (en) * | 2001-01-31 | 2009-03-17 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for stimulating weight loss and/or for lowering triglycerides in patients |
| US7202222B2 (en) * | 2003-01-06 | 2007-04-10 | National Bioscience Corporation | Methods for treatment of obesity and effective fat loss promotion |
| MXPA05011557A (es) | 2003-04-29 | 2006-03-09 | Orexigen Therapeutics Inc | Composiciones para afectar perdida de peso. |
| US8916195B2 (en) * | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| AU2008219585A1 (en) * | 2007-02-27 | 2008-09-04 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome. |
| WO2009158114A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| KR20210012056A (ko) | 2012-06-06 | 2021-02-02 | 오렉시젠 세러퓨틱스 인크. | 과체중 및 비만의 치료 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2200584A1 (de) * | 1971-01-11 | 1972-07-27 | Wyeth John & Brother Ltd | Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen |
| GB1366133A (en) * | 1971-01-11 | 1974-09-11 | Wyeth John & Brother Ltd | Fused ring indole derivatives |
| US4307234A (en) * | 1978-09-11 | 1981-12-22 | American Home Products Corp. | Pyrimido[1,6-a]indole derivatives |
-
1982
- 1982-06-21 ZA ZA824382A patent/ZA824382B/xx unknown
- 1982-06-22 US US06/391,071 patent/US4451465A/en not_active Expired - Fee Related
- 1982-06-23 AU AU85169/82A patent/AU558020B2/en not_active Ceased
- 1982-07-02 IT IT22209/82A patent/IT1157288B/it active
- 1982-07-07 BE BE0/208549A patent/BE893789A/fr not_active IP Right Cessation
- 1982-07-07 JP JP57119147A patent/JPS5815915A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU558020B2 (en) | 1987-01-15 |
| JPS5815915A (ja) | 1983-01-29 |
| IT1157288B (it) | 1987-02-11 |
| ZA824382B (en) | 1984-02-29 |
| US4451465A (en) | 1984-05-29 |
| AU8516982A (en) | 1983-01-13 |
| BE893789A (fr) | 1983-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA19680A1 (fr) | N- arylsulfonyl - n' - pyrimidinylurees. | |
| ES263653Y (es) | "boton". | |
| DK165695C (da) | 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol | |
| ES263000Y (es) | "grifo". | |
| ES264326Y (es) | "calzado". | |
| IT8222209A0 (it) | Agenti anti-obesita'. | |
| ES516683A0 (es) | "perfeccionamientos en tacografos". | |
| MX9203211A (es) | 6'-alquilespectinomicinas. | |
| FI843110A (fi) | 4'-halogenantracyklinglykosid. | |
| ES263696Y (es) | "disposicion de fiador". | |
| IT1152515B (it) | 5-fenossifenil-tetraidro-1,3,5-tiadiazin-4-oni | |
| ES264864Y (es) | "pesacartas". | |
| ES267636Y (es) | "lustrador". | |
| TR21560A (tr) | Etilsulfonilmetil-i,3 ogzazolidin herbisid antidot | |
| FI821159A0 (fi) | 2,4-dioxacyclohexanonderivat | |
| ES266634Y (es) | "zapato". | |
| ES267859Y (es) | "limpiapeines". | |
| ES267940Y (es) | "bolsa-nevera". | |
| ES267947Y (es) | "cortapelo". | |
| ES264404Y (es) | "balon-rompecabezas". | |
| ES265809Y (es) | "contenedor-expositor". | |
| ES264963Y (es) | "cartera-estera". | |
| ES264962Y (es) | "bolso-estera". | |
| ES265226Y (es) | "tapapezunas". | |
| ES265530Y (es) | "perfil-esquinero perfeccionado". |